Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by HighteawithIntrepidon Mar 29, 2018 3:42pm

174 Views

Post# 27804979

RE:RE:what is PLI cash position

Sorry did you not miss the fact we have already drawn 40 million on
the line of credit and at a burn of 30 million a quarter. The SRAM money was written
off as a bad debt and that is why the reported quarterly loss was 20 million more
than normal so we have about 6 months of loan room left.

Bullboard Posts

Changing Europe’s dependency on HREE from China